Medpace MEDP

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Medpace (MEDP) Business Model and Operations Summary
    Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

    Key Insights

    Medpace (MEDP) Core Market Data and Business Metrics
    • Latest Closing Price

      $447.92
    • Market Cap

      $13.22 Billion
    • Average Daily Volume

      423,545.5 Shares
    • 52-Week Range

      $250.05-$500.82
    • Price-Earnings Ratio

      33.25
    • Total Outstanding Shares

      28.09 Million Shares
    • CEO

      August James Troendle
    • Total Employees

      6,000
    • Current Dividend

      No dividend
    • IPO Date

      August 11, 2016
    • SIC Description

      Services-commercial Physical & Biological Research
    • Headquarters

      5375 Medpace Way, Cincinnati, OH, 45227

    Earnings Reports

    Expected vs. Actual Quarterly Earnings-Per-Share & Revenue

    Short Volume

    Daily short volume activity identifies short-term trading pressure and potential price volatility

    Short Interest

    Bi-monthly short interest levels can be used to gauge bearish market sentiment and short squeeze potential

    Revenue Breakdown

    Distribution of revenue across unique business segments & geographies

    Cash Flow Statement

    July 1, 2024 to June 30, 2025

    Income Statement

    July 1, 2024 to June 30, 2025

    Comprehensive Income

    July 1, 2024 to June 30, 2025

    Balance Sheet

    July 1, 2024 to June 30, 2025

    Historical Stock Splits

    Historical Dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about MEDP from trusted financial sources

    Related Companies

    Publicly traded companies similar to Medpace (MEDP)
    Boost your savings and earn 3.95% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.